发明名称 |
METADOXINE FOR USE AS INHIBITOR OF HEPATIC FIBROSIS |
摘要 |
<p>The use of metadoxine in the treatment of hepatic fibrosis is described. Metadoxine can be orally and/or parenterally administered at a dosage comprised between 50 and 1000 mg per dose, preferably between 300 and 600 mg per dose. In the in vitro study, metadoxine results effective at lower concentrations with respect to those that are obtained in the plasma after oral administration at the doses recommended for conventional pathology.</p> |
申请公布号 |
WO2010100619(A1) |
申请公布日期 |
2010.09.10 |
申请号 |
WO2010IB50930 |
申请日期 |
2010.03.04 |
申请人 |
LABORATORI BALDACCI SPA;BALDACCI, MASSIMO |
发明人 |
BALDACCI, MASSIMO |
分类号 |
A61K31/4015;A61K31/4415;A61P1/16 |
主分类号 |
A61K31/4015 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|